Cytochrome P450 2J2: potential role in drug metabolism and cardiotoxicity

M Solanki, A Pointon, B Jones, K Herbert - Drug Metabolism and Disposition, 2018 - ASPET
Drug-induced cardiotoxicity may be modulated by endogenous arachidonic acid (AA)–
derived metabolites known as epoxyeicosatrienoic acids (EETs) synthesized by cytochrome …

Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs

Y Zhang, L Gao, B Yao, S Huang, Y Zhang, J Liu, Z Liu… - Life Sciences, 2022 - Elsevier
Epoxyeicosatrienoic acids (EETs) are important endogenous substances that affect heart
function in human body. Animal models of cytochrome P450 (CYP) and soluble epoxide …

[HTML][HTML] Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer

H Tang, Y Kuang, W Wu, B Peng, Q Fu - Molecular Medicine, 2023 - Springer
Background Recent years have witnessed impressive growth in applying natural medicine
in tumor treatment. Saffron is reported to elicit an inhibitory property against BC. Herein, we …

[HTML][HTML] Site-directed deuteration of dronedarone preserves cytochrome P4502J2 activity and mitigates its cardiac adverse effects in canine arrhythmic hearts

AV Karkhanis, G Venkatesan, R Kambayashi… - … Pharmaceutica Sinica B, 2022 - Elsevier
Abstract Cytochrome P4502J2 (CYP2J2) metabolizes arachidonic acid (AA) to
cardioprotective epoxyeicosatrienoic acids (EETs). Dronedarone, an antiarrhythmic drug …

[HTML][HTML] Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes

JWH Leow, Y Gu, ECY Chan - European Journal of Pharmaceutical …, 2023 - Elsevier
Abstract Cardiac cytochrome P450 2J2 (CYP2J2) metabolizes endogenous polyunsaturated
fatty acid, arachidonic acid (AA), to bioactive regioisomeric epoxyeicosatrienoic acid (EET) …

Inhibition of cytochrome P450 2J2-mediated metabolism of rivaroxaban and arachidonic acid by ibrutinib and osimertinib

Z Wang, ECY Chan - Drug Metabolism and Disposition, 2022 - ASPET
Covalent tyrosine kinase inhibitors (TKIs) ibrutinib and osimertinib are associated with
cardiac arrhythmia. The interactions between these TKIs with CYP2J2 that is highly …

Cardiomyocyte-specific CYP2J2 and its therapeutic implications

R Valencia, W Bassiouni, AM Darwesh… - Expert Opinion on …, 2022 - Taylor & Francis
ABSTRACT Introduction Cytochrome P450s (CYPs) are a superfamily of monooxygenases
with diverse biological roles. CYP2J2 is an isozyme highly expressed in the heart where it …

CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control

JWH Leow, ECY Chan - Pharmacology & Therapeutics, 2024 - Elsevier
Abstract Cytochrome P450 2 J2 (CYP2J2) is primarily expressed extrahepatically and is the
predominant epoxygenase in human cardiac tissues. This highlights its key role in the …

Atypical kinetics of cytochrome P450 2J2: epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors

JWH Leow, RK Verma, ABH Lim, H Fan… - European Journal of …, 2021 - Elsevier
Extrahepatic CYP2J2 metabolism of arachidonic acid (AA) to bioactive regioisomeric
epoxyeicosatrienoic acids (EETs) is implicated in both physiological and pathological …

Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function

A Shahzadi, C Eyileten, M Postula, EG Tanoglu… - Naunyn-Schmiedeberg's …, 2023 - Springer
This study was designed to investigate the impacts of Doxo alone and in combination with
Cipro on the hepatic and cardiac CYP1A2, CYP2J3, and CYP3A1 mRNA levels. We also …